ABSTRACT
The growing use of anti-TNF drugs during the last years has reopened the discussion about the possible increased risk of developing non-Hodgkin lymphoma in patients with such type of treatments. We present our clinical experience and critical opinion about the current situation of such issue regarding cutaneous T-cell lymphomas.El creciente uso de fármacos anti-TNF durante los últimos años ha reabierto el debate sobre el posible aumento de riesgo de linfomas no Hodgkin en los pacientes con este tipo de tratamientos. Presentamos nuestra experiencia clínica y opinión critica sobre la situación actual de este tema en relación a los linfomas cutáneos de células T.
Subject(s)
Arthritis, Rheumatoid/drug therapy , Etanercept/adverse effects , Mycosis Fungoides/chemically induced , Skin Neoplasms/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Aged , Humans , Male , Mycosis Fungoides/pathology , Risk Assessment , Risk Factors , Skin/pathology , Skin Neoplasms/pathologyABSTRACT
Darier disease (DD) is an autosomal dominant genodermatosis characterized by multiple keratotic and crusted papules over seborrheic areas, along with a variable involvement of oral mucosa, palmoplantar region, and nails. Segmental subtypes (type 1 and 2) are uncommon clinically limited forms of DD that usually present at middle age with few cutaneous lesions following Blaschko´s lines. We report a case of extensive multi segmental DD type 1 that developed in an elderly man, an unusual clinical onset of DD that dermatologists should bear in mind.
Subject(s)
Darier Disease/pathology , Leg Dermatoses/pathology , Skin/pathology , Abdomen , Darier Disease/diagnosis , Darier Disease/drug therapy , Humans , Keratolytic Agents/therapeutic use , Leg Dermatoses/diagnosis , Leg Dermatoses/drug therapy , Male , Middle Aged , Tretinoin/therapeutic useSubject(s)
Antineoplastic Agents, Immunological/adverse effects , Drug Eruptions/etiology , Eosinophilia/chemically induced , Fasciitis/chemically induced , Lichen Sclerosus et Atrophicus/chemically induced , Nivolumab/adverse effects , Urinary Bladder Neoplasms/drug therapy , Humans , Male , Middle Aged , Urinary Bladder Neoplasms/pathologySubject(s)
Cytarabine/adverse effects , Ear Diseases/chemically induced , Ear, External/drug effects , Erythema/chemically induced , Leukemia, Myeloid, Acute/drug therapy , Sweet Syndrome/chemically induced , Adult , Biopsy , Cytarabine/therapeutic use , Drug Therapy, Combination , Ear Diseases/pathology , Ear, External/pathology , Erythema/diagnosis , Erythema/pathology , Follow-Up Studies , Humans , Idarubicin/therapeutic use , Male , Sweet Syndrome/diagnosis , Sweet Syndrome/pathologySubject(s)
Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium chelonae/isolation & purification , Renal Dialysis/adverse effects , Thrombophlebitis/microbiology , Aged , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Biopsy, Needle , Clarithromycin/therapeutic use , Drug Therapy, Combination , Humans , Immunohistochemistry , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/therapy , Male , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium chelonae/drug effects , Necrosis/pathology , Prognosis , Renal Dialysis/methods , Severity of Illness Index , Thrombophlebitis/drug therapy , Thrombophlebitis/etiology , Thrombophlebitis/pathology , Treatment OutcomeSubject(s)
Levofloxacin/administration & dosage , Oral Hygiene/methods , Respiratory Tract Infections , Smoking Cessation/methods , Tongue, Hairy , Anti-Bacterial Agents/administration & dosage , Female , Humans , Middle Aged , Respiratory Tract Infections/complications , Respiratory Tract Infections/drug therapy , Tongue/diagnostic imaging , Tongue, Hairy/complications , Tongue, Hairy/diagnosis , Tongue, Hairy/etiology , Tongue, Hairy/therapy , Treatment OutcomeSubject(s)
Amyloidosis/chemically induced , Antineoplastic Agents, Immunological/adverse effects , Hutchinson's Melanotic Freckle/pathology , Ipilimumab/adverse effects , Lung Neoplasms/secondary , Skin Neoplasms/pathology , Amyloidosis/pathology , Antineoplastic Agents, Immunological/therapeutic use , Biopsy, Needle , Follow-Up Studies , Humans , Hutchinson's Melanotic Freckle/surgery , Immunohistochemistry , Infusions, Intravenous , Ipilimumab/therapeutic use , Lung Neoplasms/drug therapy , Male , Middle Aged , Sentinel Lymph Node Biopsy/methods , Skin Neoplasms/surgery , Treatment OutcomeSubject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Immunotherapy , Nevus/drug therapy , Panniculitis/chemically induced , Peritoneal Neoplasms/drug therapy , Skin Neoplasms/drug therapy , Skin/pathology , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents, Immunological/adverse effects , Antineoplastic Agents, Immunological/therapeutic use , Disease Progression , Female , Follow-Up Studies , Humans , Middle Aged , Nevus/diagnosis , Panniculitis/diagnosis , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/secondary , Programmed Cell Death 1 Receptor , Skin Neoplasms/pathology , Tomography, X-Ray ComputedABSTRACT
No disponible